Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- How low can HbA1c go?
-
- Therapy for idiopathic GHD: take a break?
- Can an adolescent with bona fide GHD have a trial off of therapy?
- FDA urged to rethink its method of determining bioequivalence
- Was the mortality disparity between the high-intensity and standard treatment arms in ACCORD an authentic finding?
- Where does intensive glucose control stand now, given the study results presented at ADA?
- Don’t let hypoglycemia drag your patient down Ronald Tamler, MD, PhD, MBA
- Treating the silent, unresponsive patient Patris Toney, DPM, MPH
- Reduce inequalities in minority health care by providing culturally sensitive education Amparo Gonzalez, RN, BSN, CDE
-
- Heart disease and diabetes: a continuing controversy Alan J. Garber, MD, PhD, MACE
- The role of vitamin D for obese patients in reversing the type 2 diabetes pandemic David S.H. Bell, MB, FACE, FACP
- Penicillin: An accidental discovery changed the course of medicine Katie Kalvaitis
- Radioactive iodine uptake in a mediastinal mass Stephanie L. Lee, MD, PhD, ECNU
- ‘Why did this have to happen…?’ Richard O. Dolinar, MD
- Bilateral oophorectomy before menopause associated with increased risk for metabolic syndrome
- Bisphosphonates, calcitonin, raloxifene similarly effective in preventing nonvertebral fractures
- Erectile dysfunction linked to coronary heart disease events
-
- Increased serum adiponectin levels predicted progression to ESRD
- Sugar-sweetened, fruit drink consumption increased diabetes risk in black women
- USC endocrinologist, veteran provides aid for underprivileged in Vietnam
- Dietary supplements: the good, bad and ugly June Felice Johnson, BS, PharmD, FASHP, CDM-diabetes